Find a TenderPlanned procurementPreliminary market engagement notice
Published 28 Sept 2026, 11:47 BST

Official UK procurement notice

Antiretroviral Drugs · UK public procurement notice

Authority: NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) (NHS & healthcare)

GoodsAbove thresholdSME suitableVCSE suitable
Planned pipeline value£1,512,963pipeline notice, not a live tender
Tender notice expected 30 Nov 2026from the planned procurement notice
Contract term 1 yr 3 moends 30 Jun 2028 · up to 30 Jun 2029 with extensions · starts 1 Apr 2027

What is being bought

Published requirement description

Supply of Antiretroviral Drugs which are all shortly due to lose their patent exclusivity (or have previously lost their exclusivity) and therefore will have competition available in the UK.

CPV: Pharmaceutical products

The lotProcurement structure

single lot · no lot value published
Lot #1PlannedRenewal 1 yr 3 moSMEVCSE
Contract period: 1 Apr 2027 – 30 Jun 2028 (1 yr 3 mo) · up to 30 Jun 2029 with extensions
Delivery: WalesEligibility: SME eligibleVCSE eligible
Extensions: Extension options published

Who is likely to bid for this lot ↓

Pipeline intelligence · planning stage: how this market runs before the tender is published

How NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) buys Pharmaceutical products (CPV 3360), and who usually turns up

NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust)’s published record next to the market for the same work. Frameworks and DPS are left out: they draw different bid counts. Whole-market view: Pharmaceutical products (CPV 3360) →

1

How the contest usually goes

Winner shares use published awards; bid and price charts use contested lots.

How often do SMEs win?
i

The counts under this question show how many awards have a known supplier size.

Buyer: 27 of 137 known-size awards · market: CPV 3360 · Wales (Cymru), n=159
20%11%

Small firms have won here. Neither number says whether you qualify; it describes who has been winning. 159 known-size awards sit across 15 procurements, so one procurement can dominate this percentage.

How often do local suppliers win?
i

Local means the winner is registered in the region where that award was delivered. The market figure counts awards delivered in Wales (Cymru).

Buyer: 40 of 75 known-location awards · market: CPV 3360 · Wales (Cymru), n=53
53%91%

Most of this buyer’s recorded winners were registered in the region where that award was delivered.

How long to a decision?
i
Buyer: 9 decided notices · market: CPV 3360 · Wales (Cymru), n=7
31 days31 days

Half of these awards have an award date within 31 days of the bid deadline.

How often single-bid or direct?
i

The buyer’s share is a minimum: some awards have no bid count.

Buyer: at least 34 of 53 procurements with awards had no recorded rival · market: CPV 3360 · Wales (Cymru), n=13
64%15%

Direct awards or one recorded bid are common here. Check the route before spending time on a bid.

How many bids did past lots attract?

i
This buyer29 lots with bid counts · broad CPV 33
10% had one bid
The market14 lots with bid counts · CPV 3360 · Wales (Cymru)
0% had one bid
% of lots with a published bid count: this buyer (29) / the market (14) · select a colour for counts
1 bid10% / 0%
Buyer: 3 of 29 lots with published bid counts. Market: 0 of 14 lots with published bid counts.
2–328% / 21%
Buyer: 8 of 29 lots with published bid counts. Market: 3 of 14 lots with published bid counts.
4–628% / 14%
Buyer: 8 of 29 lots with published bid counts. Market: 2 of 14 lots with published bid counts.
7+34% / 64%
Buyer: 10 of 29 lots with published bid counts. Market: 9 of 14 lots with published bid counts.

How did awards compare with estimates?

i
This buyer65 lots with estimate and award · all categories
46% below estimate
The market8 lots with estimate and award · CPV 3360 · UK-wide
38% below estimate
% of lots with an estimate and award: this buyer (65) / the market (8) · select a colour for counts
Below estimate46% / 38%
Buyer: 30 of 65 lots with an estimate and award. Market: 3 of 8 lots with an estimate and award.
Within ±2%32% / 38%
Buyer: 21 of 65 lots with an estimate and award. Market: 3 of 8 lots with an estimate and award.
Above estimate22% / 25%
Buyer: 14 of 65 lots with an estimate and award. Market: 2 of 8 lots with an estimate and award.
2

Assess each lot
i

Open a lot for its forecast, this buyer’s previous supplier and possible competitors, from published award history, not a bid list

Lot #1CPV 336015 monthsSME suitablePublished estimate£1.5m
Expected competition
i

Each lot shows its own forecast based on its own category; forecasts for different lots of the same notice are not comparative. The bar shows 14 past lots.

—No model forecast yet0% chance of a single bid
Past bids on 14 similar lots
1 bid0%
0 of 14 similar past lots received 1 bid (0%).
2–321%
3 of 14 similar past lots received 2–3 (21%).
4–614%
2 of 14 similar past lots received 4–6 (14%).
7+64%
9 of 14 similar past lots received 7+ (64%).
Comparable past lots usually drew 14.5 bids.
Commercial price forecast
i

No comparable awards for this lot yet.

—No model forecast yet
No comparable awards on record for this lot’s category yet. The published estimate is £1.5m, and the forecast stays empty until the market has a record to read.

Who has supplied this buyer on similar work?
i

SupplierThis buyer’s earlier contractLotAward valueWhy listed
Gilead Sciences LtdLive contractAntiretroviral Drugsruns to Jun 2028—£20mMatched as the earlier contract
ViiV HealthcareLive contractAntiretroviral Drugsruns to Jun 2028—£12mMatched as the earlier contract
JanssenLive contractAntiretroviral Drugsruns to Jun 2028—£3.0mMatched as the earlier contract
Lupin Healthcare UK LtdLive contractAntiretroviral Drugsruns to Jun 2028—£1.1mMatched as the earlier contract
Merck Sharpe and Dohme (UK) LimitedLive contractAntiretroviral Drugsruns to Jun 2028—£581kMatched as the earlier contract

Who could compete for this lot?
i

Candidate suppliers for this notice have not been worked out yet, so this is not a verdict that nobody fits.

About this data
  • Estimates, labelled. The price range, possible competitors and earlier-work matches are our estimates from past awards, not published facts, win chances or price advice. The buyer’s own record and the wider market are shown apart, never mixed.
  • Source. Official UK public procurement notices (Find a Tender and Contracts Finder), reused under the Open Government Licence v3.0, updated through the day and rebuilt nightly. Not every figure uses both feeds, and each one shows how many records it rests on: see the methodology. Spotted something wrong? Tell us.

What this replaces
i

100% title match.

The prior contract this notice most likely re-tenders · matched by title and category (100% title match), the holder is not guaranteed to re-bid

Antiretroviral Drugs — held by Gilead Sciences Ltd and ViiV Healthcare (+1 more); the published contract ends 30 Jun 2028.

Coming up in this sector

Contracts ending within 12 months · Retender Radar, sector filter set

Procedure terms & legal framework

From the official record
Legal basis
UKPGA · 2023/54 Procurement Act 2023
Procurement category
Goods
Notice status
Planned procurement
Procurement threshold
Above threshold (FTS publication)
Regulatory regime
Standard
Commercial structure
Stand-alone contract (no framework)
Competition type
Competitive procedure
GPA / WTO covered
Unspecified in notice
Recurring procurement
Unspecified in notice
First published
28 Sept 2026, 11:47 BST
Last source update
28 Sept 2026, 11:47 BST
FTS notice number
2026/S 000-091362
Latest notice
Preliminary market engagement notice (UK2)
Classification (CPV)
Pharmaceutical products
Delivery area
Wales (UKL)
Official registry OCID
ocds-h6vhtk-077b5f Find a Tender

How it was run

Official notice
Submission deadline
—

Timeline

28 Sept 2026 → 1 Apr 2027 · 4 dates
  1. Planning notice published46 days ago
    28 Sept 2026, 11:47 BST
  2. Market engagement7 days ago
    6 Nov 2026, 23:59 GMT

    This notice is being issued to advise suppliers of a forthcoming opportunity that is due to be published by Velindre NHS Trust, NHS Shared Services Partnership - Procurement Services (on behalf of All Wales Health Boards and Trusts).

    This contract is for Antiretroviral Drugs which are all shortly due to lose their patent exclusivity (or have previously lost their exclusivity) and therefore will have competition available in the UK.

    There is no formal engagement process for this opportunity.

    Any suppliers who may like more information on this opportunity before the tender is published please contact Rachelle Elvin ([email protected]).

  3. Today
    14 Nov 2026
  4. Tender notice expectedin 16 days
    30 Nov 2026, 23:59 GMT
  5. Contract startsin 137 days
    1 Apr 2027, 00:00 BST

Notice history

1 event · 1 release on Find a Tender
  1. Preliminary market engagement notice published
    28 Sept 2026, 11:47 BST
    UK2

Commercial outcome & contract awards

Pipeline notice
Awards (0)
No award published
Contracts (0)
No contract published
Bid statistics
No aggregate bid statistics published

Contracting authority & participating public bodies

NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust)

Contracting authorityPublic authority - central governmentWelsh devolved regulations apply GB-NHS: RQF Unit 5, Imperial Park, Newport, Wales, NP10 8BEContact email

Official documents & specifications (1)

Official links; attachments are not copied

Notices published for this procedure